

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 6.69584811 |
| 2 | desmosome organization (GO:0002934) | 6.48458673 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.07337592 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.79945332 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.74808488 |
| 6 | regulation of water loss via skin (GO:0033561) | 4.69850986 |
| 7 | protein localization to endosome (GO:0036010) | 4.65825001 |
| 8 | establishment of skin barrier (GO:0061436) | 4.60523872 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.53110592 |
| 10 | glutamate secretion (GO:0014047) | 4.26789088 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.23455726 |
| 12 | cell-substrate junction assembly (GO:0007044) | 4.22305352 |
| 13 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.03221714 |
| 14 | keratinization (GO:0031424) | 3.98225385 |
| 15 | locomotory exploration behavior (GO:0035641) | 3.94347665 |
| 16 | barbed-end actin filament capping (GO:0051016) | 3.84545858 |
| 17 | vocalization behavior (GO:0071625) | 3.83122879 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 3.76230508 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.67814201 |
| 20 | NADH metabolic process (GO:0006734) | 3.66150736 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.65010596 |
| 22 | neuronal action potential propagation (GO:0019227) | 3.64036424 |
| 23 | skin morphogenesis (GO:0043589) | 3.60668320 |
| 24 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.51227828 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 3.48160497 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 3.48160497 |
| 27 | sodium ion export (GO:0071436) | 3.45227014 |
| 28 | protein localization to synapse (GO:0035418) | 3.44896624 |
| 29 | activation of protein kinase A activity (GO:0034199) | 3.41904544 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.41293489 |
| 31 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.39410344 |
| 32 | multicellular organismal water homeostasis (GO:0050891) | 3.37720704 |
| 33 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.36563262 |
| 34 | regulation of early endosome to late endosome transport (GO:2000641) | 3.35691950 |
| 35 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.34384334 |
| 36 | cell-substrate adherens junction assembly (GO:0007045) | 3.31306546 |
| 37 | focal adhesion assembly (GO:0048041) | 3.31306546 |
| 38 | layer formation in cerebral cortex (GO:0021819) | 3.31220535 |
| 39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.28758771 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 3.26293421 |
| 41 | neuromuscular process controlling posture (GO:0050884) | 3.25917233 |
| 42 | protein retention in ER lumen (GO:0006621) | 3.24284447 |
| 43 | adherens junction assembly (GO:0034333) | 3.19896574 |
| 44 | keratinocyte proliferation (GO:0043616) | 3.17743977 |
| 45 | epithelial cell-cell adhesion (GO:0090136) | 3.13253122 |
| 46 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.10457750 |
| 47 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.08968831 |
| 48 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.08006146 |
| 49 | proline transport (GO:0015824) | 3.07721089 |
| 50 | cell communication by electrical coupling (GO:0010644) | 3.07111587 |
| 51 | regulation of vesicle fusion (GO:0031338) | 3.06642373 |
| 52 | exploration behavior (GO:0035640) | 3.06393111 |
| 53 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.05492898 |
| 54 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.01811113 |
| 55 | cell communication involved in cardiac conduction (GO:0086065) | 2.99963074 |
| 56 | neurotransmitter transport (GO:0006836) | 2.99156837 |
| 57 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.93462532 |
| 58 | neuron cell-cell adhesion (GO:0007158) | 2.90482656 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 2.89859839 |
| 60 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.87590581 |
| 61 | glycine transport (GO:0015816) | 2.87033246 |
| 62 | adhesion of symbiont to host cell (GO:0044650) | 2.86924687 |
| 63 | virion attachment to host cell (GO:0019062) | 2.86924687 |
| 64 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.84179802 |
| 65 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.83723336 |
| 66 | response to pheromone (GO:0019236) | 2.80462549 |
| 67 | positive regulation of vesicle fusion (GO:0031340) | 2.78712043 |
| 68 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.78677865 |
| 69 | potassium ion homeostasis (GO:0055075) | 2.76497993 |
| 70 | GDP-mannose metabolic process (GO:0019673) | 2.76111312 |
| 71 | stress fiber assembly (GO:0043149) | 2.74778542 |
| 72 | positive regulation of synapse maturation (GO:0090129) | 2.73465347 |
| 73 | regulation of neurotransmitter levels (GO:0001505) | 2.73407016 |
| 74 | positive regulation of pseudopodium assembly (GO:0031274) | 2.72560406 |
| 75 | axon cargo transport (GO:0008088) | 2.72030908 |
| 76 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.71698849 |
| 77 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70409312 |
| 78 | synaptic vesicle endocytosis (GO:0048488) | 2.69866002 |
| 79 | adhesion of symbiont to host (GO:0044406) | 2.69600936 |
| 80 | hypotonic response (GO:0006971) | 2.68313211 |
| 81 | membrane depolarization during action potential (GO:0086010) | 2.67977054 |
| 82 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.67713257 |
| 83 | negative regulation of microtubule polymerization (GO:0031115) | 2.67457716 |
| 84 | regulation of pseudopodium assembly (GO:0031272) | 2.67221800 |
| 85 | neuromuscular process controlling balance (GO:0050885) | 2.67190312 |
| 86 | negative regulation of cell size (GO:0045792) | 2.66487905 |
| 87 | positive regulation of potassium ion transport (GO:0043268) | 2.65903326 |
| 88 | cerebellar Purkinje cell layer development (GO:0021680) | 2.65644940 |
| 89 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.65136602 |
| 90 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.64666789 |
| 91 | actin filament depolymerization (GO:0030042) | 2.64534998 |
| 92 | vesicle transport along microtubule (GO:0047496) | 2.64365716 |
| 93 | synaptic transmission, glutamatergic (GO:0035249) | 2.64078897 |
| 94 | water homeostasis (GO:0030104) | 2.63613629 |
| 95 | cell migration in hindbrain (GO:0021535) | 2.63088957 |
| 96 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.63034495 |
| 97 | regulation of neurotransmitter secretion (GO:0046928) | 2.62858928 |
| 98 | activation of MAPKKK activity (GO:0000185) | 2.61843673 |
| 99 | positive regulation of epidermis development (GO:0045684) | 2.60553593 |
| 100 | neuron-neuron synaptic transmission (GO:0007270) | 2.60241677 |
| 101 | organelle transport along microtubule (GO:0072384) | 2.60197591 |
| 102 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.60028765 |
| 103 | potassium ion import (GO:0010107) | 2.59796706 |
| 104 | membrane repolarization (GO:0086009) | 2.58143483 |
| 105 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.57637036 |
| 106 | mating behavior (GO:0007617) | 2.57398780 |
| 107 | activation of Rac GTPase activity (GO:0032863) | 2.57055287 |
| 108 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.55637986 |
| 109 | innervation (GO:0060384) | 2.53805728 |
| 110 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.53789065 |
| 111 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.53789065 |
| 112 | glutamate receptor signaling pathway (GO:0007215) | 2.53738930 |
| 113 | chemosensory behavior (GO:0007635) | 2.53000620 |
| 114 | regulation of necrotic cell death (GO:0010939) | 2.52586597 |
| 115 | intermediate filament organization (GO:0045109) | 2.52268182 |
| 116 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.51423409 |
| 117 | protein maturation by protein folding (GO:0022417) | 2.51323111 |
| 118 | dendrite morphogenesis (GO:0048813) | 2.51249338 |
| 119 | endothelial cell chemotaxis (GO:0035767) | 2.50831860 |
| 120 | apoptotic process involved in morphogenesis (GO:0060561) | 2.50731885 |
| 121 | cellular sodium ion homeostasis (GO:0006883) | 2.50306586 |
| 122 | positive regulation of membrane potential (GO:0045838) | 2.50196564 |
| 123 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.50146145 |
| 124 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.49407500 |
| 125 | surfactant homeostasis (GO:0043129) | 2.49120674 |
| 126 | protein targeting to plasma membrane (GO:0072661) | 2.48030121 |
| 127 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.47510620 |
| 128 | cellular copper ion homeostasis (GO:0006878) | 2.46910657 |
| 129 | dendritic spine morphogenesis (GO:0060997) | 2.46616604 |
| 130 | regulation of synaptic plasticity (GO:0048167) | 2.46385038 |
| 131 | plasma membrane repair (GO:0001778) | 2.46093210 |
| 132 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.45416778 |
| 133 | long-term memory (GO:0007616) | 2.45402438 |
| 134 | regulation of neurotransmitter transport (GO:0051588) | 2.45344122 |
| 135 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.45296743 |
| 136 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.44983196 |
| 137 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.43845498 |
| 138 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.43845387 |
| 139 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.42914047 |
| 140 | actin filament bundle organization (GO:0061572) | 2.42850723 |
| 141 | actin filament bundle assembly (GO:0051017) | 2.42850723 |
| 142 | detection of calcium ion (GO:0005513) | 2.42493666 |
| 143 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.41665097 |
| 144 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.41411928 |
| 145 | endocytic recycling (GO:0032456) | 2.41355388 |
| 146 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.40804334 |
| 147 | pinocytosis (GO:0006907) | 2.40735697 |
| 148 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.40473499 |
| 149 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.40473499 |
| 150 | membrane tubulation (GO:0097320) | 2.40018426 |
| 151 | positive regulation of receptor recycling (GO:0001921) | 2.39356544 |
| 152 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.39031084 |
| 153 | neuron recognition (GO:0008038) | 2.38806672 |
| 154 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.38801833 |
| 155 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.38291147 |
| 156 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.38066231 |
| 157 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.37754757 |
| 158 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.37609680 |
| 159 | atrioventricular valve morphogenesis (GO:0003181) | 2.37200493 |
| 160 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.36432613 |
| 161 | regulation of postsynaptic membrane potential (GO:0060078) | 2.36331151 |
| 162 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.34510643 |
| 163 | detection of temperature stimulus (GO:0016048) | 2.33983435 |
| 164 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.33897956 |
| 165 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.33060464 |
| 166 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.32891545 |
| 167 | cellular response to glucagon stimulus (GO:0071377) | 2.32600283 |
| 168 | cell adhesion mediated by integrin (GO:0033627) | 2.32164078 |
| 169 | keratinocyte differentiation (GO:0030216) | 2.32111823 |
| 170 | prostaglandin biosynthetic process (GO:0001516) | 2.28779009 |
| 171 | prostanoid biosynthetic process (GO:0046457) | 2.28779009 |
| 172 | establishment of protein localization to plasma membrane (GO:0090002) | 2.26816699 |
| 173 | peptide cross-linking (GO:0018149) | 2.26587335 |
| 174 | semaphorin-plexin signaling pathway (GO:0071526) | 2.24994499 |
| 175 | positive regulation of protein dephosphorylation (GO:0035307) | 2.23453513 |
| 176 | regulation of cholesterol homeostasis (GO:2000188) | 2.21944494 |
| 177 | gap junction assembly (GO:0016264) | 2.20394098 |
| 178 | peptidyl-proline hydroxylation (GO:0019511) | 2.20354127 |
| 179 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.19858589 |
| 180 | actin-myosin filament sliding (GO:0033275) | 2.18159797 |
| 181 | muscle filament sliding (GO:0030049) | 2.18159797 |
| 182 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.18047055 |
| 183 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.17714957 |
| 184 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.15329230 |
| 185 | cardiac muscle contraction (GO:0060048) | 2.14810158 |
| 186 | mitotic nuclear envelope reassembly (GO:0007084) | 2.13509517 |
| 187 | nuclear envelope reassembly (GO:0031468) | 2.13509517 |
| 188 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.13312210 |
| 189 | negative regulation of fatty acid transport (GO:2000192) | 2.13196845 |
| 190 | cell-cell junction maintenance (GO:0045217) | 2.12098243 |
| 191 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.11406129 |
| 192 | positive regulation of protein export from nucleus (GO:0046827) | 2.10701326 |
| 193 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.10322188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.82503615 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.12972298 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.68468669 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65326487 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53386306 |
| 6 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.50339691 |
| 7 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45211115 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.43019703 |
| 9 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.39444235 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.38742552 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38338771 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.35781921 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.35781921 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.27065453 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26585192 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16710431 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.14983091 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.14179769 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11010252 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10507465 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.09773865 |
| 22 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.07672571 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.04579352 |
| 24 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02141288 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01607780 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.98843120 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95885638 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.92185726 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85721259 |
| 30 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.83019052 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.81995628 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80922824 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.78346266 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78249901 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.73087160 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71692883 |
| 37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70908082 |
| 38 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.69603504 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66710421 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65349448 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63379985 |
| 42 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.61855888 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60223106 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60212019 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.60123063 |
| 46 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.58740433 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57178874 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57076324 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55520582 |
| 50 | ATF3_27146783_Chip-Seq_COLON_Human | 1.52277473 |
| 51 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.51335782 |
| 52 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.49195159 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48344044 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47440154 |
| 55 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.46685695 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46476634 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.46252298 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.45759104 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.42253693 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41964056 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.41880032 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41775693 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41674354 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40442246 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40046701 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39837010 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36701878 |
| 68 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35511962 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35241518 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34649774 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33150539 |
| 72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32281787 |
| 73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29930718 |
| 74 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29930718 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.26267536 |
| 76 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.24811152 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22182724 |
| 78 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20678786 |
| 79 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20216317 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19781447 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19664611 |
| 82 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18766655 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18492692 |
| 84 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18323695 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18266608 |
| 86 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17885933 |
| 87 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.17832153 |
| 88 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17790394 |
| 89 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14299571 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14269359 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.14226217 |
| 92 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13536682 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13505014 |
| 94 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13422568 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13224918 |
| 96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12933921 |
| 97 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10709595 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10709595 |
| 99 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10526574 |
| 100 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10263323 |
| 101 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09326882 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08694332 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08392744 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07963009 |
| 105 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07710419 |
| 106 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07415766 |
| 107 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.06645043 |
| 108 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04541555 |
| 109 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04138649 |
| 110 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03739007 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03699578 |
| 112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03512004 |
| 113 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02506524 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02081458 |
| 115 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.01663667 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01538591 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99811905 |
| 118 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99781374 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99724333 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98893906 |
| 121 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98039584 |
| 122 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97962718 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97233879 |
| 124 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97227522 |
| 125 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96880044 |
| 126 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96473388 |
| 127 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96471446 |
| 128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96374734 |
| 129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95426851 |
| 130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95218988 |
| 131 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94395589 |
| 132 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93861134 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93858125 |
| 134 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93803386 |
| 135 | * AR_19668381_ChIP-Seq_PC3_Human | 0.93651528 |
| 136 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92637190 |
| 137 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.92456022 |
| 138 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92227666 |
| 139 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91689926 |
| 140 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91447698 |
| 141 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91351253 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91067899 |
| 143 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90775824 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90284739 |
| 145 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90141836 |
| 146 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.90006088 |
| 147 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89557310 |
| 148 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.89324102 |
| 149 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88882388 |
| 150 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88716087 |
| 151 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.87600988 |
| 152 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86994255 |
| 153 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86928353 |
| 154 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84778077 |
| 155 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83892992 |
| 156 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82881993 |
| 157 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82473073 |
| 158 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82135716 |
| 159 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82132462 |
| 160 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81880851 |
| 161 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81823304 |
| 162 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81752734 |
| 163 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80853080 |
| 164 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.79868691 |
| 165 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79498745 |
| 166 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79410427 |
| 167 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.78065865 |
| 168 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77901496 |
| 169 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.77723814 |
| 170 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76763878 |
| 171 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76710821 |
| 172 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76380538 |
| 173 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76312086 |
| 174 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76027905 |
| 175 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.75051418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.72197292 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 4.50668341 |
| 3 | MP0004270_analgesia | 3.57063357 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.16174425 |
| 5 | MP0003880_abnormal_central_pattern | 3.10299422 |
| 6 | MP0005451_abnormal_body_composition | 2.88634547 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.87327977 |
| 8 | MP0005501_abnormal_skin_physiology | 2.69852076 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.68266084 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.63411103 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.54493699 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.53918432 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.47150902 |
| 14 | MP0009745_abnormal_behavioral_response | 2.46254626 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.44909840 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.41598783 |
| 17 | MP0009046_muscle_twitch | 2.39447652 |
| 18 | MP0009840_abnormal_foam_cell | 2.39218412 |
| 19 | MP0004510_myositis | 2.38138706 |
| 20 | MP0002064_seizures | 2.37664140 |
| 21 | MP0004858_abnormal_nervous_system | 2.35748733 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.30551889 |
| 23 | MP0003329_amyloid_beta_deposits | 2.28449466 |
| 24 | MP0002736_abnormal_nociception_after | 2.25469465 |
| 25 | MP0005409_darkened_coat_color | 2.15153533 |
| 26 | MP0008260_abnormal_autophagy | 2.13846126 |
| 27 | MP0002272_abnormal_nervous_system | 2.11998694 |
| 28 | MP0002060_abnormal_skin_morphology | 2.10475425 |
| 29 | MP0005058_abnormal_lysosome_morphology | 2.09379391 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 2.06332842 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 2.04322763 |
| 32 | MP0001970_abnormal_pain_threshold | 2.00324795 |
| 33 | MP0000751_myopathy | 1.99913096 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.99697776 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.99104003 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.97702059 |
| 37 | MP0002822_catalepsy | 1.91160855 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.90114489 |
| 39 | MP0001216_abnormal_epidermal_layer | 1.90035458 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.89824440 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.88178849 |
| 42 | MP0000467_abnormal_esophagus_morphology | 1.79916894 |
| 43 | MP0001849_ear_inflammation | 1.78152171 |
| 44 | MP0004947_skin_inflammation | 1.75090877 |
| 45 | MP0001440_abnormal_grooming_behavior | 1.74883187 |
| 46 | MP0001486_abnormal_startle_reflex | 1.68865549 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.66375493 |
| 48 | MP0000762_abnormal_tongue_morphology | 1.65044834 |
| 49 | MP0003941_abnormal_skin_development | 1.64802621 |
| 50 | MP0005023_abnormal_wound_healing | 1.63218506 |
| 51 | MP0009379_abnormal_foot_pigmentation | 1.62756652 |
| 52 | MP0002184_abnormal_innervation | 1.61688570 |
| 53 | MP0004272_abnormal_basement_membrane | 1.61387936 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.60812935 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.56734469 |
| 56 | MP0000678_abnormal_parathyroid_gland | 1.56223460 |
| 57 | MP0002098_abnormal_vibrissa_morphology | 1.55503880 |
| 58 | MP0008569_lethality_at_weaning | 1.54560781 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.53057090 |
| 60 | MP0001958_emphysema | 1.51750717 |
| 61 | MP0010771_integument_phenotype | 1.50352014 |
| 62 | MP0000750_abnormal_muscle_regeneration | 1.43620364 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.43302565 |
| 64 | MP0000955_abnormal_spinal_cord | 1.42494560 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.39914738 |
| 66 | MP0005257_abnormal_intraocular_pressure | 1.39877427 |
| 67 | MP0003879_abnormal_hair_cell | 1.39353999 |
| 68 | MP0010386_abnormal_urinary_bladder | 1.38957311 |
| 69 | MP0002796_impaired_skin_barrier | 1.34324909 |
| 70 | MP0005330_cardiomyopathy | 1.32587217 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.31999910 |
| 72 | MP0004885_abnormal_endolymph | 1.31931891 |
| 73 | MP0004043_abnormal_pH_regulation | 1.30440802 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.28739179 |
| 75 | MP0004924_abnormal_behavior | 1.26304779 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.26304779 |
| 77 | MP0000858_altered_metastatic_potential | 1.25192931 |
| 78 | MP0005165_increased_susceptibility_to | 1.23871989 |
| 79 | MP0003633_abnormal_nervous_system | 1.23208840 |
| 80 | MP0003091_abnormal_cell_migration | 1.22648209 |
| 81 | MP0004087_abnormal_muscle_fiber | 1.21592233 |
| 82 | MP0005375_adipose_tissue_phenotype | 1.20541514 |
| 83 | MP0000747_muscle_weakness | 1.19523490 |
| 84 | MP0004142_abnormal_muscle_tone | 1.18265252 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.17628124 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 1.16651823 |
| 87 | MP0008961_abnormal_basal_metabolism | 1.16531860 |
| 88 | MP0005166_decreased_susceptibility_to | 1.16389402 |
| 89 | MP0005666_abnormal_adipose_tissue | 1.15070363 |
| 90 | MP0000377_abnormal_hair_follicle | 1.13829926 |
| 91 | MP0000778_abnormal_nervous_system | 1.13006662 |
| 92 | MP0001984_abnormal_olfaction | 1.12166772 |
| 93 | MP0009931_abnormal_skin_appearance | 1.11607478 |
| 94 | MP0003283_abnormal_digestive_organ | 1.11046280 |
| 95 | MP0000749_muscle_degeneration | 1.08634559 |
| 96 | MP0003279_aneurysm | 1.07418150 |
| 97 | MP0002229_neurodegeneration | 1.06242815 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 1.06129765 |
| 99 | MP0002234_abnormal_pharynx_morphology | 1.05646009 |
| 100 | MP0000733_abnormal_muscle_development | 1.05293162 |
| 101 | MP0004036_abnormal_muscle_relaxation | 1.03908567 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 1.03761306 |
| 103 | MP0005646_abnormal_pituitary_gland | 1.02417670 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 1.01950045 |
| 105 | MP0004381_abnormal_hair_follicle | 1.01620956 |
| 106 | MP0000604_amyloidosis | 1.00717315 |
| 107 | MP0006138_congestive_heart_failure | 0.97527590 |
| 108 | MP0002090_abnormal_vision | 0.97356112 |
| 109 | MP0003631_nervous_system_phenotype | 0.97355027 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.94519149 |
| 111 | MP0003300_gastrointestinal_ulcer | 0.94036649 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.94029774 |
| 113 | MP0002896_abnormal_bone_mineralization | 0.93878046 |
| 114 | MP0004085_abnormal_heartbeat | 0.93394338 |
| 115 | MP0005535_abnormal_body_temperature | 0.93354198 |
| 116 | MP0000579_abnormal_nail_morphology | 0.93246204 |
| 117 | MP0004130_abnormal_muscle_cell | 0.90616081 |
| 118 | MP0003828_pulmonary_edema | 0.90553135 |
| 119 | MP0001243_abnormal_dermal_layer | 0.90323684 |
| 120 | MP0003634_abnormal_glial_cell | 0.89793494 |
| 121 | MP0001299_abnormal_eye_distance/ | 0.89230496 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 0.88146737 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.87507211 |
| 124 | MP0005360_urolithiasis | 0.87176368 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.86887865 |
| 126 | MP0000566_synostosis | 0.86236397 |
| 127 | MP0004215_abnormal_myocardial_fiber | 0.85918765 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.85279590 |
| 129 | MP0005645_abnormal_hypothalamus_physiol | 0.84845991 |
| 130 | MP0009053_abnormal_anal_canal | 0.83749036 |
| 131 | MP0001905_abnormal_dopamine_level | 0.83643639 |
| 132 | MP0000343_altered_response_to | 0.83261523 |
| 133 | MP0003646_muscle_fatigue | 0.82862761 |
| 134 | MP0004233_abnormal_muscle_weight | 0.82860475 |
| 135 | MP0003436_decreased_susceptibility_to | 0.82750679 |
| 136 | MP0005275_abnormal_skin_tensile | 0.82631417 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.81738146 |
| 138 | MP0008874_decreased_physiological_sensi | 0.78241983 |
| 139 | MP0002972_abnormal_cardiac_muscle | 0.78176155 |
| 140 | MP0000462_abnormal_digestive_system | 0.78050864 |
| 141 | MP0003303_peritoneal_inflammation | 0.77964046 |
| 142 | MP0000537_abnormal_urethra_morphology | 0.77847245 |
| 143 | MP0001765_abnormal_ion_homeostasis | 0.77106060 |
| 144 | MP0001986_abnormal_taste_sensitivity | 0.76821752 |
| 145 | MP0005620_abnormal_muscle_contractility | 0.76463954 |
| 146 | MP0002089_abnormal_postnatal_growth/wei | 0.75463889 |
| 147 | MP0010368_abnormal_lymphatic_system | 0.75462572 |
| 148 | MP0000920_abnormal_myelination | 0.74630282 |
| 149 | MP0003195_calcinosis | 0.74445257 |
| 150 | MP0005623_abnormal_meninges_morphology | 0.74223522 |
| 151 | MP0001664_abnormal_digestion | 0.74090117 |
| 152 | MP0002269_muscular_atrophy | 0.72903042 |
| 153 | MP0003137_abnormal_impulse_conducting | 0.72536219 |
| 154 | MP0005083_abnormal_biliary_tract | 0.71152021 |
| 155 | MP0004484_altered_response_of | 0.71055690 |
| 156 | MP0008872_abnormal_physiological_respon | 0.70927742 |
| 157 | MP0010630_abnormal_cardiac_muscle | 0.69501949 |
| 158 | MP0005187_abnormal_penis_morphology | 0.68429544 |
| 159 | MP0003632_abnormal_nervous_system | 0.66803169 |
| 160 | MP0002078_abnormal_glucose_homeostasis | 0.66569763 |
| 161 | MP0003806_abnormal_nucleotide_metabolis | 0.66281609 |
| 162 | MP0002998_abnormal_bone_remodeling | 0.65522505 |
| 163 | MP0001542_abnormal_bone_strength | 0.65451605 |
| 164 | MP0005167_abnormal_blood-brain_barrier | 0.64763422 |
| 165 | MP0003075_altered_response_to | 0.64066576 |
| 166 | MP0000230_abnormal_systemic_arterial | 0.64006211 |
| 167 | MP0004084_abnormal_cardiac_muscle | 0.64004836 |
| 168 | MP0000759_abnormal_skeletal_muscle | 0.63767180 |
| 169 | MP0001533_abnormal_skeleton_physiology | 0.63670735 |
| 170 | MP0002152_abnormal_brain_morphology | 0.63645417 |
| 171 | MP0003448_altered_tumor_morphology | 0.63365767 |
| 172 | MP0001851_eye_inflammation | 0.62999816 |
| 173 | MP0000367_abnormal_coat/_hair | 0.61930960 |
| 174 | MP0003950_abnormal_plasma_membrane | 0.60509801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.27421865 |
| 2 | Visual hallucinations (HP:0002367) | 4.20264271 |
| 3 | Focal motor seizures (HP:0011153) | 4.18051809 |
| 4 | Distal lower limb muscle weakness (HP:0009053) | 4.00273788 |
| 5 | Abnormality of nail color (HP:0100643) | 3.90762287 |
| 6 | Atrophic scars (HP:0001075) | 3.73430700 |
| 7 | Focal seizures (HP:0007359) | 3.64968950 |
| 8 | Action tremor (HP:0002345) | 3.58781876 |
| 9 | Onycholysis (HP:0001806) | 3.48649679 |
| 10 | Atonic seizures (HP:0010819) | 3.42461687 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.38106850 |
| 12 | Plantar hyperkeratosis (HP:0007556) | 3.34232707 |
| 13 | Distal lower limb amyotrophy (HP:0008944) | 3.31836037 |
| 14 | Fragile nails (HP:0001808) | 3.30068904 |
| 15 | Milia (HP:0001056) | 3.25340621 |
| 16 | Ankle clonus (HP:0011448) | 3.15734708 |
| 17 | Ventricular fibrillation (HP:0001663) | 3.14083428 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.12464592 |
| 19 | Pheochromocytoma (HP:0002666) | 3.07178531 |
| 20 | Increased connective tissue (HP:0009025) | 3.02724622 |
| 21 | Absence seizures (HP:0002121) | 3.02282562 |
| 22 | Alopecia of scalp (HP:0002293) | 3.01687337 |
| 23 | Epileptic encephalopathy (HP:0200134) | 3.01579593 |
| 24 | Thick nail (HP:0001805) | 2.99757617 |
| 25 | Nail dystrophy (HP:0008404) | 2.92536938 |
| 26 | Fragile skin (HP:0001030) | 2.92098967 |
| 27 | Palmoplantar hyperkeratosis (HP:0000972) | 2.86338601 |
| 28 | Axonal loss (HP:0003447) | 2.85972537 |
| 29 | Generalized tonic-clonic seizures (HP:0002069) | 2.82758797 |
| 30 | Type 1 muscle fiber predominance (HP:0003803) | 2.82619119 |
| 31 | Premature rupture of membranes (HP:0001788) | 2.81501788 |
| 32 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.80184519 |
| 33 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.76920859 |
| 34 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.74345723 |
| 35 | Febrile seizures (HP:0002373) | 2.73856288 |
| 36 | Depression (HP:0000716) | 2.71021673 |
| 37 | Hypercortisolism (HP:0001578) | 2.69541710 |
| 38 | Ventricular tachycardia (HP:0004756) | 2.65437979 |
| 39 | Dialeptic seizures (HP:0011146) | 2.63934257 |
| 40 | Protrusio acetabuli (HP:0003179) | 2.63711841 |
| 41 | Anxiety (HP:0000739) | 2.61054471 |
| 42 | Neuroendocrine neoplasm (HP:0100634) | 2.59341767 |
| 43 | Myotonia (HP:0002486) | 2.56140233 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.55620274 |
| 45 | Neurofibrillary tangles (HP:0002185) | 2.54889694 |
| 46 | Palmar hyperkeratosis (HP:0010765) | 2.54479341 |
| 47 | Lower limb amyotrophy (HP:0007210) | 2.50359937 |
| 48 | Ulnar claw (HP:0001178) | 2.49574275 |
| 49 | Exercise-induced myalgia (HP:0003738) | 2.47972444 |
| 50 | Pili torti (HP:0003777) | 2.47305902 |
| 51 | Cerebral inclusion bodies (HP:0100314) | 2.45929877 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.45784281 |
| 53 | Abnormal blistering of the skin (HP:0008066) | 2.44336596 |
| 54 | Dysdiadochokinesis (HP:0002075) | 2.39375211 |
| 55 | Myopathic facies (HP:0002058) | 2.37190874 |
| 56 | Ridged nail (HP:0001807) | 2.36027138 |
| 57 | Termporal pattern (HP:0011008) | 2.35827888 |
| 58 | Insidious onset (HP:0003587) | 2.35827888 |
| 59 | Sudden death (HP:0001699) | 2.35536242 |
| 60 | Hypotrichosis (HP:0001006) | 2.35292579 |
| 61 | Increased IgE level (HP:0003212) | 2.34860660 |
| 62 | Agitation (HP:0000713) | 2.33656815 |
| 63 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.33249638 |
| 64 | Torticollis (HP:0000473) | 2.32229188 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.30862512 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.29680236 |
| 67 | Limb dystonia (HP:0002451) | 2.28496563 |
| 68 | Abnormality of the lower motor neuron (HP:0002366) | 2.28179049 |
| 69 | Dysmetria (HP:0001310) | 2.27817149 |
| 70 | Muscle fiber inclusion bodies (HP:0100299) | 2.26844462 |
| 71 | Amblyopia (HP:0000646) | 2.25449205 |
| 72 | Rapidly progressive (HP:0003678) | 2.24870541 |
| 73 | Bundle branch block (HP:0011710) | 2.24389832 |
| 74 | Erythema (HP:0010783) | 2.24118307 |
| 75 | Nemaline bodies (HP:0003798) | 2.23196524 |
| 76 | Spinal rigidity (HP:0003306) | 2.20826661 |
| 77 | Mutism (HP:0002300) | 2.19524060 |
| 78 | Intention tremor (HP:0002080) | 2.17185862 |
| 79 | Cerebral aneurysm (HP:0004944) | 2.13336500 |
| 80 | Truncal ataxia (HP:0002078) | 2.11440888 |
| 81 | Achilles tendon contracture (HP:0001771) | 2.11305476 |
| 82 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.11039424 |
| 83 | Acanthosis nigricans (HP:0000956) | 2.10770602 |
| 84 | Natal tooth (HP:0000695) | 2.10667870 |
| 85 | Postural instability (HP:0002172) | 2.10579746 |
| 86 | Hyperacusis (HP:0010780) | 2.08392134 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 2.08203459 |
| 88 | Abnormal hair laboratory examination (HP:0003328) | 2.07736092 |
| 89 | Focal dystonia (HP:0004373) | 2.07712469 |
| 90 | Abnormal social behavior (HP:0012433) | 2.07334158 |
| 91 | Impaired social interactions (HP:0000735) | 2.07334158 |
| 92 | Malnutrition (HP:0004395) | 2.06928601 |
| 93 | Poor eye contact (HP:0000817) | 2.06098250 |
| 94 | Central scotoma (HP:0000603) | 2.03940289 |
| 95 | Prolonged QT interval (HP:0001657) | 2.03856798 |
| 96 | Hypoventilation (HP:0002791) | 2.03474724 |
| 97 | Scanning speech (HP:0002168) | 2.02875454 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 2.01611963 |
| 99 | Postural tremor (HP:0002174) | 2.01608968 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01281297 |
| 101 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01281297 |
| 102 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01281297 |
| 103 | Craniofacial dystonia (HP:0012179) | 2.01253559 |
| 104 | Bulbar palsy (HP:0001283) | 2.00807489 |
| 105 | Syncope (HP:0001279) | 2.00497984 |
| 106 | Round ear (HP:0100830) | 1.99911844 |
| 107 | Thin bony cortex (HP:0002753) | 1.97970383 |
| 108 | Muscle fiber splitting (HP:0003555) | 1.97624166 |
| 109 | EMG: myopathic abnormalities (HP:0003458) | 1.96792613 |
| 110 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.94882580 |
| 111 | EEG with generalized epileptiform discharges (HP:0011198) | 1.93737015 |
| 112 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.93194130 |
| 113 | Epileptiform EEG discharges (HP:0011182) | 1.93108270 |
| 114 | Urinary urgency (HP:0000012) | 1.89467995 |
| 115 | Distal upper limb amyotrophy (HP:0007149) | 1.89066972 |
| 116 | Upper limb amyotrophy (HP:0009129) | 1.89066972 |
| 117 | Hammertoe (HP:0001765) | 1.88601453 |
| 118 | Megalencephaly (HP:0001355) | 1.88372960 |
| 119 | Broad face (HP:0000283) | 1.87883906 |
| 120 | Abnormal EKG (HP:0003115) | 1.87422898 |
| 121 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.87048113 |
| 122 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86417298 |
| 123 | Adrenal overactivity (HP:0002717) | 1.85677407 |
| 124 | Short nail (HP:0001799) | 1.85632391 |
| 125 | Neck muscle weakness (HP:0000467) | 1.85153101 |
| 126 | Rigidity (HP:0002063) | 1.84761390 |
| 127 | Failure to thrive in infancy (HP:0001531) | 1.84165597 |
| 128 | Spastic gait (HP:0002064) | 1.84051280 |
| 129 | Foot dorsiflexor weakness (HP:0009027) | 1.84033568 |
| 130 | Ketoacidosis (HP:0001993) | 1.83912676 |
| 131 | Advanced eruption of teeth (HP:0006288) | 1.83682404 |
| 132 | Right ventricular cardiomyopathy (HP:0011663) | 1.83150083 |
| 133 | Trismus (HP:0000211) | 1.83102072 |
| 134 | Palmoplantar keratoderma (HP:0000982) | 1.82819701 |
| 135 | Osteolytic defects of the hand bones (HP:0009699) | 1.82467413 |
| 136 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82467413 |
| 137 | Bradycardia (HP:0001662) | 1.81905322 |
| 138 | Hypsarrhythmia (HP:0002521) | 1.81802839 |
| 139 | Bradykinesia (HP:0002067) | 1.81793558 |
| 140 | Ragged-red muscle fibers (HP:0003200) | 1.81725661 |
| 141 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.81305205 |
| 142 | Genetic anticipation (HP:0003743) | 1.80701820 |
| 143 | Gout (HP:0001997) | 1.79545745 |
| 144 | Delusions (HP:0000746) | 1.79510188 |
| 145 | Elbow flexion contracture (HP:0002987) | 1.79314001 |
| 146 | Generalized amyotrophy (HP:0003700) | 1.78975413 |
| 147 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78042629 |
| 148 | Abnormal atrioventricular conduction (HP:0005150) | 1.77871394 |
| 149 | Hyperparathyroidism (HP:0000843) | 1.77823342 |
| 150 | Status epilepticus (HP:0002133) | 1.77804224 |
| 151 | Cholecystitis (HP:0001082) | 1.77771231 |
| 152 | Abnormal gallbladder physiology (HP:0012438) | 1.77771231 |
| 153 | Muscle stiffness (HP:0003552) | 1.77318380 |
| 154 | Increased circulating renin level (HP:0000848) | 1.77201946 |
| 155 | Clonus (HP:0002169) | 1.76976287 |
| 156 | Abnormality of the foot musculature (HP:0001436) | 1.74833134 |
| 157 | Papilledema (HP:0001085) | 1.74371770 |
| 158 | Lower limb muscle weakness (HP:0007340) | 1.74223743 |
| 159 | Difficulty running (HP:0009046) | 1.73901834 |
| 160 | Difficulty climbing stairs (HP:0003551) | 1.72914392 |
| 161 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.72096349 |
| 162 | Hand muscle atrophy (HP:0009130) | 1.72050793 |
| 163 | Eczematoid dermatitis (HP:0000976) | 1.71605614 |
| 164 | Obstructive sleep apnea (HP:0002870) | 1.71381621 |
| 165 | Neuronal loss in central nervous system (HP:0002529) | 1.71018082 |
| 166 | Abnormality of pain sensation (HP:0010832) | 1.70338206 |
| 167 | Impaired pain sensation (HP:0007328) | 1.70338206 |
| 168 | Rhabdomyolysis (HP:0003201) | 1.69979482 |
| 169 | Onion bulb formation (HP:0003383) | 1.68060641 |
| 170 | Neonatal death (HP:0003811) | 1.67873977 |
| 171 | Vascular tortuosity (HP:0004948) | 1.66999811 |
| 172 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66056808 |
| 173 | Growth hormone excess (HP:0000845) | 1.66030441 |
| 174 | Abnormality of the salivary glands (HP:0010286) | 1.65307703 |
| 175 | Back pain (HP:0003418) | 1.65182410 |
| 176 | Stridor (HP:0010307) | 1.65083482 |
| 177 | Wormian bones (HP:0002645) | 1.63900258 |
| 178 | Scapular winging (HP:0003691) | 1.61871677 |
| 179 | Spinal cord compression (HP:0002176) | 1.61546198 |
| 180 | Amyloidosis (HP:0011034) | 1.61268398 |
| 181 | Ulnar bowing (HP:0003031) | 1.60528051 |
| 182 | Polygenic inheritance (HP:0010982) | 1.60442362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.54057538 |
| 2 | EPHA2 | 3.40316270 |
| 3 | NTRK3 | 3.13788730 |
| 4 | TESK1 | 2.81334988 |
| 5 | NME2 | 2.65640132 |
| 6 | TTN | 2.60010531 |
| 7 | MINK1 | 2.55520555 |
| 8 | IRAK3 | 2.54062911 |
| 9 | KSR2 | 2.50655622 |
| 10 | PRPF4B | 2.49753406 |
| 11 | MAP3K4 | 2.39955448 |
| 12 | MARK1 | 2.33212801 |
| 13 | NTRK1 | 2.30720724 |
| 14 | EPHA4 | 2.29861291 |
| 15 | PAK6 | 2.26748497 |
| 16 | MAP3K2 | 2.05307956 |
| 17 | MAP2K4 | 2.02026822 |
| 18 | PRKD3 | 2.00210622 |
| 19 | SMG1 | 1.99495192 |
| 20 | SIK1 | 1.91888609 |
| 21 | DAPK2 | 1.91001425 |
| 22 | PHKG1 | 1.87572120 |
| 23 | PHKG2 | 1.87572120 |
| 24 | GRK5 | 1.84837428 |
| 25 | ARAF | 1.70888046 |
| 26 | MAP2K7 | 1.69374229 |
| 27 | EPHB2 | 1.69238184 |
| 28 | MAP3K12 | 1.66366347 |
| 29 | FER | 1.62879337 |
| 30 | LMTK2 | 1.60686574 |
| 31 | MAP3K3 | 1.59756783 |
| 32 | PIM2 | 1.56374063 |
| 33 | LATS2 | 1.54201970 |
| 34 | TESK2 | 1.53601764 |
| 35 | PINK1 | 1.51480857 |
| 36 | CAMKK1 | 1.50740955 |
| 37 | TAOK2 | 1.44270611 |
| 38 | ICK | 1.40781781 |
| 39 | PAK4 | 1.38004198 |
| 40 | CAMKK2 | 1.34887437 |
| 41 | MAPKAPK3 | 1.32334764 |
| 42 | NTRK2 | 1.31747457 |
| 43 | RET | 1.30730385 |
| 44 | MYLK | 1.30067182 |
| 45 | ABL2 | 1.28079820 |
| 46 | CDK5 | 1.26266666 |
| 47 | STK38 | 1.25490915 |
| 48 | PAK3 | 1.24549793 |
| 49 | PDGFRA | 1.24192398 |
| 50 | PKN2 | 1.23586041 |
| 51 | MET | 1.20794340 |
| 52 | UHMK1 | 1.20532854 |
| 53 | LIMK1 | 1.19502303 |
| 54 | MOS | 1.17915959 |
| 55 | MAP3K1 | 1.17872677 |
| 56 | WNK4 | 1.17171808 |
| 57 | TRIB3 | 1.16290167 |
| 58 | RIPK1 | 1.16119079 |
| 59 | MAP2K3 | 1.15529657 |
| 60 | TAOK1 | 1.14711324 |
| 61 | EPHB1 | 1.14006631 |
| 62 | ILK | 1.03849491 |
| 63 | TBK1 | 1.03579217 |
| 64 | TGFBR2 | 1.00668124 |
| 65 | EEF2K | 0.98638550 |
| 66 | KSR1 | 0.98554925 |
| 67 | NME1 | 0.96076728 |
| 68 | PTK6 | 0.91359980 |
| 69 | MAP2K1 | 0.91163361 |
| 70 | SGK223 | 0.90735538 |
| 71 | SGK494 | 0.90735538 |
| 72 | CAMK2A | 0.90117585 |
| 73 | PRKCH | 0.87214051 |
| 74 | PRKD2 | 0.86674687 |
| 75 | RPS6KA2 | 0.85462182 |
| 76 | WNK1 | 0.84334337 |
| 77 | PRKCG | 0.80237883 |
| 78 | CAMK2D | 0.79986952 |
| 79 | CAMK2G | 0.79662366 |
| 80 | CDK14 | 0.79465875 |
| 81 | CDK19 | 0.79062427 |
| 82 | TYRO3 | 0.78384393 |
| 83 | NEK1 | 0.76799327 |
| 84 | OXSR1 | 0.76430550 |
| 85 | MAPK12 | 0.74988360 |
| 86 | MARK2 | 0.73965634 |
| 87 | CAMK2B | 0.73787899 |
| 88 | PLK2 | 0.73639350 |
| 89 | SCYL2 | 0.73232762 |
| 90 | PTK2 | 0.72390869 |
| 91 | MST1R | 0.72249224 |
| 92 | INSRR | 0.71012111 |
| 93 | MUSK | 0.70837500 |
| 94 | MAPK13 | 0.70460255 |
| 95 | DAPK1 | 0.68585933 |
| 96 | WNK3 | 0.67749198 |
| 97 | STK11 | 0.66776406 |
| 98 | PDPK1 | 0.66012020 |
| 99 | CDK15 | 0.65558172 |
| 100 | CDK18 | 0.64697417 |
| 101 | STK39 | 0.62698774 |
| 102 | IRAK2 | 0.61913364 |
| 103 | CSNK1G2 | 0.61362471 |
| 104 | PRKCE | 0.60496229 |
| 105 | CASK | 0.59598625 |
| 106 | CAMK1 | 0.59517069 |
| 107 | PTK2B | 0.58429838 |
| 108 | RIPK4 | 0.58249695 |
| 109 | MAP2K2 | 0.57820386 |
| 110 | CDC42BPA | 0.57312442 |
| 111 | DMPK | 0.56004974 |
| 112 | CDK11A | 0.55272507 |
| 113 | LRRK2 | 0.55073350 |
| 114 | DAPK3 | 0.54649535 |
| 115 | KDR | 0.53738732 |
| 116 | MTOR | 0.53643532 |
| 117 | MAP3K6 | 0.53583186 |
| 118 | PRKD1 | 0.52503101 |
| 119 | MAP3K11 | 0.51874631 |
| 120 | BRAF | 0.51691613 |
| 121 | MAPKAPK5 | 0.51123083 |
| 122 | BMX | 0.50293346 |
| 123 | HIPK2 | 0.49579557 |
| 124 | ALK | 0.48814265 |
| 125 | RPS6KL1 | 0.48571316 |
| 126 | RPS6KC1 | 0.48571316 |
| 127 | FES | 0.48251721 |
| 128 | PRKCZ | 0.47063233 |
| 129 | PDK1 | 0.46936390 |
| 130 | OBSCN | 0.46914549 |
| 131 | MAP3K13 | 0.46803524 |
| 132 | RAF1 | 0.46290260 |
| 133 | MAP3K7 | 0.45769635 |
| 134 | PAK2 | 0.45714979 |
| 135 | ROCK2 | 0.45316536 |
| 136 | ERN1 | 0.44990841 |
| 137 | SIK2 | 0.44848281 |
| 138 | MAP2K6 | 0.44473875 |
| 139 | ROCK1 | 0.44037559 |
| 140 | DDR2 | 0.43968956 |
| 141 | PRKG2 | 0.43715039 |
| 142 | MAP3K8 | 0.43101391 |
| 143 | MAPK15 | 0.42933712 |
| 144 | EPHA3 | 0.42551853 |
| 145 | RPS6KB2 | 0.42306015 |
| 146 | MAPK4 | 0.40142303 |
| 147 | MAPK11 | 0.38304095 |
| 148 | PRKCI | 0.37214547 |
| 149 | AKT2 | 0.37040407 |
| 150 | ZAP70 | 0.37030535 |
| 151 | PAK1 | 0.35120195 |
| 152 | MAPKAPK2 | 0.31929219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.00166284 |
| 2 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.34010191 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.28184519 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.24259190 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.23211331 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.08902197 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 2.05687210 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.99356396 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.97661011 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.88097653 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.86131179 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82151884 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.81516770 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81179813 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.75848895 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.75147539 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.72145383 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.70946107 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62900265 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61921888 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.60588179 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.57412225 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.57203113 |
| 24 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.55782530 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.54655974 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51067930 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49792342 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48570920 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47917268 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.43306444 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41797811 |
| 32 | Focal adhesion_Homo sapiens_hsa04510 | 1.41715453 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40931271 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39823694 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.39617907 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.38815414 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.35539585 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34732250 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.34598380 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.31351193 |
| 41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.31002353 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.26667005 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26593254 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26466710 |
| 45 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.23730053 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.21669741 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.13577613 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11742857 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11555230 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09391340 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.07880806 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07780877 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05686212 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02953437 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01860388 |
| 56 | * Lysosome_Homo sapiens_hsa04142 | 1.01382078 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01285851 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 1.00102305 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99618248 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99518627 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98957301 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98907807 |
| 63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.95827098 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95594886 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.95573323 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94078235 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.92574213 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89628358 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.88221994 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85184094 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84852968 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84166811 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82872486 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82731673 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82707986 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81712042 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80262373 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80227533 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79811662 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.79366611 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.79013225 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78794225 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77977222 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77949922 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.77766435 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77128333 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76984324 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.76738837 |
| 89 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76705927 |
| 90 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76541947 |
| 91 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76020524 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.75442098 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75040625 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74623308 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74066266 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72765123 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72100080 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70575932 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70323914 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69236078 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68974577 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.68663829 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67537809 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66993643 |
| 105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.66911432 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66611813 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66468018 |
| 108 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65754095 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64997308 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64222702 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64030700 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.63030784 |
| 113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62754128 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62534667 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.62136303 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61543004 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61509097 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58843571 |
| 119 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58694253 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.57618180 |
| 121 | Adherens junction_Homo sapiens_hsa04520 | 0.57488725 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.56817009 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56736609 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55557932 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53231770 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.53042602 |
| 127 | Phototransduction_Homo sapiens_hsa04744 | 0.52576703 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51712585 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50904228 |
| 130 | * Endocytosis_Homo sapiens_hsa04144 | 0.49370387 |
| 131 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49363918 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48124878 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48087962 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47799284 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45578405 |
| 136 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45446409 |
| 137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45365270 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44809080 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42978732 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41005674 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.40836462 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39409932 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39307793 |
| 144 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37920245 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37363909 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36557410 |
| 147 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36333347 |
| 148 | Bladder cancer_Homo sapiens_hsa05219 | 0.36144153 |
| 149 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35776068 |
| 150 | Tight junction_Homo sapiens_hsa04530 | 0.35551869 |
| 151 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35298253 |
| 152 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34750444 |

